Pfizer Limited (BOM:500680)

ShockWave Medical Statistics

Total Valuation

Pfizer has a market cap or net worth of INR 232.88 billion. The enterprise value is 206.14 billion.

Market Cap	232.88B
Enterprise Value	206.14B

Important Dates

The next estimated earnings date is Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	Jul 9, 2025

Share Statistics

Current Share Class	45.75M
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	-0.01%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	15.12M

Valuation Ratios

The trailing PE ratio is 30.34 and the forward PE ratio is 34.16.

PE Ratio	30.34
Forward PE	34.16
PS Ratio	10.21
PB Ratio	5.52
P/TBV Ratio	6.35
P/FCF Ratio	36.87
P/OCF Ratio	35.30
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 27.86, with an EV/FCF ratio of 32.64.

EV / Earnings	26.85
EV / Sales	9.04
EV / EBITDA	27.86
EV / EBIT	30.26
EV / FCF	32.64

Financial Position

The company has a current ratio of 6.17, with a Debt / Equity ratio of 0.03.

Current Ratio	6.17
Quick Ratio	5.26
Debt / Equity	0.03
Debt / EBITDA	0.15
Debt / FCF	0.17
Interest Coverage	81.00

Financial Efficiency

Return on equity (ROE) is 19.65% and return on invested capital (ROIC) is 10.62%.

Return on Equity (ROE)	19.65%
Return on Assets (ROA)	9.32%
Return on Invested Capital (ROIC)	10.62%
Return on Capital Employed (ROCE)	15.69%
Revenue Per Employee	14.28M
Profits Per Employee	4.80M
Employee Count	1,598
Asset Turnover	0.50
Inventory Turnover	1.79

Taxes

In the past 12 months, Pfizer has paid 2.48 billion in taxes.

Income Tax	2.48B
Effective Tax Rate	24.46%

Stock Price Statistics

The stock price has decreased by -11.56% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-11.56%
50-Day Moving Average	5,554.75
200-Day Moving Average	4,903.88
Relative Strength Index (RSI)	33.25
Average Volume (20 Days)	1,626

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Pfizer had revenue of INR 22.81 billion and earned 7.68 billion in profits. Earnings per share was 167.79.

Revenue	22.81B
Gross Profit	14.66B
Operating Income	6.81B
Pretax Income	10.16B
Net Income	7.68B
EBITDA	7.05B
EBIT	6.81B
Earnings Per Share (EPS)	167.79

Balance Sheet

The company has 27.83 billion in cash and 1.08 billion in debt, giving a net cash position of 26.74 billion.

Cash & Cash Equivalents	27.83B
Total Debt	1.08B
Net Cash	26.74B
Net Cash Per Share	n/a
Equity (Book Value)	42.17B
Book Value Per Share	921.88
Working Capital	29.43B

Cash Flow

In the last 12 months, operating cash flow was 6.60 billion and capital expenditures -281.50 million, giving a free cash flow of 6.32 billion.

Operating Cash Flow	6.60B
Capital Expenditures	-281.50M
Free Cash Flow	6.32B
FCF Per Share	n/a

Margins

Gross margin is 64.24%, with operating and profit margins of 29.86% and 33.65%.

Gross Margin	64.24%
Operating Margin	29.86%
Pretax Margin	44.54%
Profit Margin	33.65%
EBITDA Margin	30.91%
EBIT Margin	29.86%
FCF Margin	27.69%

Dividends & Yields

This stock pays an annual dividend of 165.00, which amounts to a dividend yield of 3.30%.

Dividend Per Share	165.00
Dividend Yield	3.30%
Dividend Growth (YoY)	371.43%
Years of Dividend Growth	n/a
Payout Ratio	20.88%
Buyback Yield	n/a
Shareholder Yield	3.30%
Earnings Yield	3.30%
FCF Yield	2.71%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pfizer has an Altman Z-Score of 22 and a Piotroski F-Score of 5.

Altman Z-Score	22
Piotroski F-Score	5